Trials / Completed
CompletedNCT05086445
A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to learn about the side effects of LY3502970 when given to Japanese participants with type 2 diabetes mellitus (T2DM). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. For each participant, the study will last up to 24 weeks, inclusive of screening and will include 10 visits to the study center.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY3502970 | Administered orally |
| DRUG | Placebo | Administered orally |
Timeline
- Start date
- 2021-11-12
- Primary completion
- 2022-09-05
- Completion
- 2022-09-05
- First posted
- 2021-10-21
- Last updated
- 2022-11-28
Locations
5 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT05086445. Inclusion in this directory is not an endorsement.